Compare NEOG & IMAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEOG | IMAX |
|---|---|---|
| Founded | 1981 | 1967 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 2.1B |
| IPO Year | 1995 | 1997 |
| Metric | NEOG | IMAX |
|---|---|---|
| Price | $9.51 | $36.17 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | $10.67 | ★ $44.50 |
| AVG Volume (30 Days) | ★ 2.7M | 949.2K |
| Earning Date | 04-09-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.25 |
| EPS | 0.02 | ★ 0.07 |
| Revenue | ★ $894,661,000.00 | $410,212,000.00 |
| Revenue This Year | N/A | $9.79 |
| Revenue Next Year | N/A | $7.51 |
| P/E Ratio | $466.25 | ★ $60.44 |
| Revenue Growth | N/A | ★ 16.47 |
| 52 Week Low | $4.53 | $22.54 |
| 52 Week High | $11.43 | $43.16 |
| Indicator | NEOG | IMAX |
|---|---|---|
| Relative Strength Index (RSI) | 50.98 | 43.78 |
| Support Level | $8.98 | $35.89 |
| Resistance Level | $10.12 | $37.52 |
| Average True Range (ATR) | 0.36 | 1.40 |
| MACD | 0.00 | 0.08 |
| Stochastic Oscillator | 56.25 | 49.49 |
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
Imax Corp is a technology platform for entertainment and events. Through its proprietary software, auditorium architecture, patented intellectual property, and specialized equipment, IMAX offers end-to-end solution to create superior, immersive content experiences for which the IMAX brand is globally renowned. The Company has two reportable segments being Content Solutions and Technology Products and Services. The Company leverages its proprietary technology and engineering in all aspects of its business, which principally consists of the IMAX film remastering and the sale or lease of premium IMAX theater systems.